LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Raising argenx SE (ARGX) FY 26 Estimate To 34.10 From 32.50 11/14/2025 10:59:15 PM
  • Wedbush Is Increasing argenx SE (ARGX) Q4 26 Estimate To 9.60 From 9.20 11/14/2025 10:59:03 PM
  • Wedbush Is Increasing argenx SE (ARGX) Q3 26 Estimate To 8.95 From 8.56 11/14/2025 10:58:52 PM
  • Wedbush Is Increasing argenx SE (ARGX) Q2 26 Estimate To 8.16 From 7.78 11/14/2025 10:58:42 PM
  • Wedbush Is Increasing argenx SE (ARGX) Q1 26 Estimate To 7.36 From 7.00 11/14/2025 10:58:30 PM
  • Wedbush Is Raising argenx SE (ARGX) FY 25 Estimate To 18.91 From 18.58 11/14/2025 10:58:19 PM
  • Wedbush Is Raising argenx SE (ARGX) Q4 25 Estimate To 6.48 From 6.15 11/14/2025 10:58:05 PM
  • Wedbush Reiterates argenx SE (ARGX) At Outperform With $1000 Up From $880 Price Target 11/14/2025 10:56:29 PM
  • Argenx Gets Health Canada Approval For VYVGART SC To Treat Chronic Inflammatory Demyelinating Polyneuropathy 11/5/2025 9:58:09 AM
  • Argenx SE Q3 Income Rises 10/30/2025 2:30:43 AM
  • Argenx Q3 EPS Rises To EUR 5.18 From EUR 1.39 Last Year 10/30/2025 2:09:30 AM
  • Argenx Showcases New VYVGART Data In GMG At AANEM And MGFA 2025 10/29/2025 11:06:08 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap